Notably, low COMT methylation has also been detected in saliva samples from schizophrenia and bipolar disorder patients, suggesting potential cross-tissue relevance and supporting the development of non-invasive biomarkers (Abdolmaleky et al., 2006). This evidence concerns the gene COMT and schizophrenia.